Last reviewed · How we verify

Qutenza — Competitive Intelligence Brief

Qutenza (CAPSAICIN) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: capsaicin. Area: Immunology.

marketed capsaicin Transient receptor potential cation channel subfamily V member 1 Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Qutenza (CAPSAICIN) — Averitas.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Qutenza TARGET CAPSAICIN Averitas marketed capsaicin Transient receptor potential cation channel subfamily V member 1 2009-01-01
Cortisporin NEOMYCIN Pfizer marketed Aminoglycoside Antibacterial Transient receptor potential cation channel subfamily V member 1 1957-01-01
Neomycin B FRAMYCETIN phase 3 framycetin Lecithin retinol acyltransferase, Menin, Transient receptor potential cation channel subfamily V member 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (capsaicin class)

  1. Averitas · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Qutenza — Competitive Intelligence Brief. https://druglandscape.com/ci/capsaicin. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: